Administration of molecular hydrogen during pregnancy improves behavioral abnormalities of offspring in a maternal immune activation model

Sci Rep. 2018 Jun 15;8(1):9221. doi: 10.1038/s41598-018-27626-4.


The aim of the present study was to investigate long-term outcomes of the offspring in a lipopolysaccharide (LPS)-induced maternal immune activation (MIA) model and the effect of maternal molecular hydrogen (H2) administration. We have previously demonstrated in the MIA mouse model that maternal administration of H2 attenuates oxidative damage and neuroinflammation, including induced pro-inflammatory cytokines and microglial activation, in the fetal brain. Short-term memory, sociability and social novelty, and sensorimotor gating were evaluated using the Y-maze, three-chamber, and prepulse inhibition (PPI) tests, respectively, at postnatal 3 or 4 weeks. The number of neurons and oligodendrocytes was also analyzed at postnatal 5 weeks by immunohistochemical analysis. Offspring of the LPS-exposed dams showed deficits in short-term memory and social interaction, following neuronal and oligodendrocytic loss in the amygdala and cortex. Maternal H2 administration markedly attenuated these LPS-induced abnormalities. Moreover, we evaluated the effect of H2 on LPS-induced astrocytic activation, both in vivo and in vitro. The number of activated astrocytes with hypertrophic morphology was increased in LPS-exposed offspring, but decreased in the offspring of H2-administered dams. In primary cultured astrocytes, LPS-induced pro-inflammatory cytokines were attenuated by H2 administration. Overall, these findings indicate that maternal H2 administration exerts neuroprotective effects and ameliorates MIA-induced neurodevelopmental deficits of offspring later in life.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain* / immunology
  • Brain* / pathology
  • Brain* / physiopathology
  • Encephalitis* / chemically induced
  • Encephalitis* / immunology
  • Encephalitis* / physiopathology
  • Encephalitis* / prevention & control
  • Female
  • Fetus / immunology
  • Fetus / pathology
  • Hydrogen / pharmacology*
  • Lipopolysaccharides / toxicity
  • Maternal Exposure / adverse effects*
  • Maze Learning / drug effects
  • Memory / drug effects
  • Mice
  • Mice, Inbred ICR
  • Neuroprotective Agents / pharmacology*
  • Pregnancy
  • Prenatal Exposure Delayed Effects* / immunology
  • Prenatal Exposure Delayed Effects* / pathology
  • Prenatal Exposure Delayed Effects* / physiopathology
  • Prenatal Exposure Delayed Effects* / prevention & control
  • Social Behavior


  • Lipopolysaccharides
  • Neuroprotective Agents
  • Hydrogen